Safety and tumour hypoxia modifying effect of buparlisib with radiotherapy in NSCLC: a phase I dose escalation study
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Elsevier
2018
|
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Elsevier
2018
|